Western blot (WB): | 1:500-5000 |
Immunohistochemistry (IHC): | 1:50-400 |
Immunofluorescence(IF): | 1:50-400 |
Flow Cytometry (Fixed): | 1:50-200 |
(Boiling the paraffin sections in 10mM citrate buffer,pH6.0,or PH8.0 EDTA repair liquid for 20 mins is required for the staining of formalin/paraffin sections.) Optimal working dilutions must be determined by end user. |
Western blot analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human placenta tissue lysates,
Lane 2: Caco-2 whole cell lysates,
Lane 3: A549 whole cell lysates,
Lane 4: A431 whole cell lysates,
Lane 5: rat liver tissue lysates,
Lane 6: rat thymus tissue lysates,
Lane 7: mouse liver tissue lysates,
Lane 8: mouse thymus tissue lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-Cytokeratin 18/KRT18 antigen affinity purified polyclonal antibody (A01357-1) at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody (Catalog # BA1054). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Cytokeratin 18/KRT18 at approximately 48 kDa. The expected band size for Cytokeratin 18/KRT18 is at 48 kDa.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of mouse intestine tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of mouse kidney tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of rat intestine tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of rat kidney tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of human intestinal cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of human placenta tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IF analysis of Cytokeratin 18 using anti-Cytokeratin 18 antibody (A01357-1)
Cytokeratin 18 was detected in paraffin-embedded section of human intestinal cancer tissuesanti-Cytokeratin 18 Antibody (A01357-1) . Biotin conjugated goat anti-rabbit IgG (BA1003) was used as secondary antibody . The tissue section was developed using Cy3 Conjugated Avidin (BA1037). The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
IF analysis of Cytokeratin 18 using anti-Cytokeratin 18 antibody (A01357-1)
Cytokeratin 18 was detected in paraffin-embedded section of human lung cancer tissuesanti-Cytokeratin 18 Antibody (A01357-1) . Biotin conjugated goat anti-rabbit IgG (BA1003) was used as secondary antibody . The tissue section was developed using Cy3 Conjugated Avidin (BA1037). The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
Flow Cytometry analysis of A431 cells using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Overlay histogram showing A431 cells stained with A01357-1 (Blue line). To facilitate intracellular staining, cells were fixed with 4% paraformaldehyde and permeabilized with permeabilization buffer. The cells were blocked with 10% normal goat serum. And then incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at 1:100 dilution for 30 min at 20°C. DyLight®488 conjugated goat anti-rabbit IgG (BA1127) was used as secondary antibody at 1:100 dilution for 30 minutes at 20°C. Isotype control antibody (Green line) was rabbit IgG at 1:100 dilution used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.
Western blot analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1). The sample well of each lane was loaded with 30 ug of sample under reducing conditions.
Lane 1: human placenta tissue lysates,
Lane 2: Caco-2 whole cell lysates,
Lane 3: A549 whole cell lysates,
Lane 4: A431 whole cell lysates,
Lane 5: rat liver tissue lysates,
Lane 6: rat thymus tissue lysates,
Lane 7: mouse liver tissue lysates,
Lane 8: mouse thymus tissue lysates.
After electrophoresis, proteins were transferred to a membrane. Then the membrane was incubated with rabbit anti-Cytokeratin 18/KRT18 antigen affinity purified polyclonal antibody (A01357-1) at a dilution of 1:1000 and probed with a goat anti-rabbit IgG-HRP secondary antibody (Catalog # BA1054). The signal is developed using ECL Plus Western Blotting Substrate (Catalog # AR1197). A specific band was detected for Cytokeratin 18/KRT18 at approximately 48 kDa. The expected band size for Cytokeratin 18/KRT18 is at 48 kDa.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of mouse intestine tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of mouse kidney tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of rat intestine tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of rat kidney tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of human intestinal cancer tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IHC analysis of Cytokeratin 18/KRT18 using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Cytokeratin 18/KRT18 was detected in a paraffin-embedded section of human placenta tissue. Biotinylated goat anti-rabbit IgG was used as secondary antibody. The tissue section was incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at a dilution of 1:200 and developed using Strepavidin-Biotin-Complex (SABC) (Catalog # SA1022) with DAB (Catalog # AR1027) as the chromogen.
IF analysis of Cytokeratin 18 using anti-Cytokeratin 18 antibody (A01357-1)
Cytokeratin 18 was detected in paraffin-embedded section of human intestinal cancer tissuesanti-Cytokeratin 18 Antibody (A01357-1) . Biotin conjugated goat anti-rabbit IgG (BA1003) was used as secondary antibody . The tissue section was developed using Cy3 Conjugated Avidin (BA1037). The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
IF analysis of Cytokeratin 18 using anti-Cytokeratin 18 antibody (A01357-1)
Cytokeratin 18 was detected in paraffin-embedded section of human lung cancer tissuesanti-Cytokeratin 18 Antibody (A01357-1) . Biotin conjugated goat anti-rabbit IgG (BA1003) was used as secondary antibody . The tissue section was developed using Cy3 Conjugated Avidin (BA1037). The section was counterstained with DAPI. Visualize using a fluorescence microscope and filter sets appropriate for the label used.
Flow Cytometry analysis of A431 cells using anti-Cytokeratin 18/KRT18 antibody (A01357-1).
Overlay histogram showing A431 cells stained with A01357-1 (Blue line). To facilitate intracellular staining, cells were fixed with 4% paraformaldehyde and permeabilized with permeabilization buffer. The cells were blocked with 10% normal goat serum. And then incubated with rabbit anti-Cytokeratin 18/KRT18 Antibody (A01357-1) at 1:100 dilution for 30 min at 20°C. DyLight®488 conjugated goat anti-rabbit IgG (BA1127) was used as secondary antibody at 1:100 dilution for 30 minutes at 20°C. Isotype control antibody (Green line) was rabbit IgG at 1:100 dilution used under the same conditions. Unlabelled sample without incubation with primary antibody and secondary antibody (Red line) was used as a blank control.